Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1/A IPO registration
- 1.1 Form of Underwriting Agreement
- 4.2 Form of Representative's Warrant Agreement
- 4.15 Amendment No. 2 to Senior Secured Promissory Note Dated As of November 21, 2017 by and Between Adial Pharmaceuticals, L.L.C. As Predecessor-in-interest to Adial Pharmaceuticals, Inc. and Firstfire Global Opportunities Fund, LLC
- 4.16 Form of Secured Promissory Notes Dated As of November 21, 2017 by and Between Adial Pharmaceuticals, Inc. and Certain Investors
- 4.17 Form of Common Stock Purchase Warrant Dated November 20, 2017 by and Among Adial Pharmaceuticals, Inc. Certain Investors
- 5.1 Opinion of Gracin & Marlow, LLP
- 10.21 Securities Purchase Agreement Dated As of November 20, 2017 by and Among Adial Pharmaceuticals, Inc. and the Investors Named Therein
- 10.22 Form of Security Agreement
- 23.1 Consent of Friedman LLP
ADIL similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the inclusion in this Amendment No. 3 to the Registration Statement on Form S-1 (File No. 333-220368) of our report dated May 11, 2017, which includes an explanatory paragraph as to the company’s ability to continue as going concern, with respect to the financial statements of ADial Pharmaceuticals, L.L.C. as of December 31, 2016 and 2015 and for the years then ended. We also consent to the reference to our firm under the heading “Experts” in such Registration Statement.
/s/ Friedman LLP
East Hanover, New Jersey
November 22, 2017